Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Thorax
    November 2024
  1. PALJARVI T, Forton JT, Thompson C, Luciano S, et al
    Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma.
    Thorax. 2024 Nov 22:thorax-2024-221590. doi: 10.1136/thorax-2024-221590.
    >> Share

  2. EVANGELOPOULOS D, Zhang H, Chatzidiakou L, Walton H, et al
    Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?
    Thorax. 2024;79:1116-1123.
    >> Share

  3. HERMANN EA, Motahari A, Hoffman EA, Sun Y, et al
    Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study.
    Thorax. 2024 Nov 4:thorax-2024-222002. doi: 10.1136/thorax-2024-222002.
    >> Share

    October 2024
  4. YEN FS, Hsu CC, Wei JC, Tsai FJ, et al
    Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD.
    Thorax. 2024;79:1017-1023.
    >> Share

  5. PHILIP J, Chang YK, Collins A, Smallwood N, et al
    Consensus palliative care referral criteria for people with chronic obstructive pulmonary disease.
    Thorax. 2024;79:1006-1016.
    >> Share

  6. LO D, Lawson C, Gillies C, Shabnam S, et al
    Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study.
    Thorax. 2024;79:1050-1059.
    >> Share

    September 2024
  7. FILIPOW N, Turner S, Petsky HL, Chang AB, et al
    Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma.
    Thorax. 2024 Sep 27:thorax-2024-221755. doi: 10.1136/thorax-2024-221755.
    >> Share

  8. BRUSTAD N, Thorsen J, Pedersen CET, Ali M, et al
    Urban metabolic and airway immune profiles increase the risk of infections in early childhood.
    Thorax. 2024;79:943-952.
    >> Share

    August 2024
  9. NORDLUND B
    Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds.
    Thorax. 2024 Aug 17:thorax-2024-222111. doi: 10.1136/thorax-2024-222111.
    >> Share

    July 2024
  10. TATON O, Gevenois PA, Van Muylem A, Bondue B, et al
    Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction.
    Thorax. 2024;79:711-717.
    >> Share

  11. LICSKAI C, Hussey A, Rowley V, Ferrone M, et al
    Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study.
    Thorax. 2024;79:725-734.
    >> Share

  12. GERSHON AS, Blazer A, Ko D
    Undertreating cardiovascular disease in people with chronic obstructive pulmonary disease (COPD).
    Thorax. 2024;79:705-706.
    >> Share

  13. GRANELL R, Haider S, Deliu M, Ullah A, et al
    Lung function trajectories from school age to adulthood and their relationship with markers of cardiovascular disease risk.
    Thorax. 2024;79:770-777.
    >> Share

  14. AMEGADZIE JE, Gao Z, Quint JK, Russell R, et al
    QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
    Thorax. 2024;79:718-724.
    >> Share

  15. KARP T, Faiz A, van Nijnatten J, Kerstjens HAM, et al
    Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study.
    Thorax. 2024 Jul 15:thorax-2023-221230. doi: 10.1136/thorax-2023-221230.
    >> Share

    May 2024
  16. GHOSH M, Vladar EK
    Extensive airway remodelling in severe COPD imparts resiliency to environmental stressors.
    Thorax. 2024;79:491-492.
    >> Share

  17. KOEFOED HJL, Wang G, Gehring U, Ekstrom S, et al
    Clinical implications of airway obstruction with normal or low FEV(1) in childhood and adolescence.
    Thorax. 2024;79:573-580.
    >> Share

  18. LIANG C, Chung HF, Dobson A, Sandin S, et al
    Female reproductive histories and the risk of chronic obstructive pulmonary disease.
    Thorax. 2024;79:508-514.
    >> Share

  19. STOLERIU MG, Ansari M, Strunz M, Schamberger A, et al
    COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors.
    Thorax. 2024;79:524-537.
    >> Share

    April 2024
  20. JENKINS AR, Burtin C, Camp PG, Lindenauer P, et al
    Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.
    Thorax. 2024;79:438-447.
    >> Share

  21. WU T, Santos S, Quezada-Pinedo HG, Vernooij MW, et al
    Body composition and respiratory outcomes in children: a population-based prospective cohort study.
    Thorax. 2024;79:448-456.
    >> Share

  22. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    >> Share

    March 2024
  23. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    >> Share

  24. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    >> Share

  25. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    >> Share

  26. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    >> Share

  27. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    >> Share

  28. WANG KCW, Blakey JD
    Impacts of sex and gender on severe asthma.
    Thorax. 2024 Mar 7:thorax-2023-221117. doi: 10.1136/thorax-2023-221117.
    >> Share

  29. MORGAN AD
    Unravelling the obesity-asthma connection in childhood and adolescence: does body shape matter?
    Thorax. 2024 Mar 7:thorax-2023-221345. doi: 10.1136/thorax-2023-221345.
    >> Share

    February 2024
  30. WILKINSON AJK, Maslova E, Janson C, Radhakrishnan V, et al
    Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
    Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
    >> Share

  31. KOUIS P, Galanakis E, Michaelidou E, Kinni P, et al
    Improved childhood asthma control after exposure reduction interventions for desert dust and anthropogenic air pollution: the MEDEA randomised controlled trial.
    Thorax. 2024 Feb 22:thorax-2023-220877. doi: 10.1136/thorax-2023-220877.
    >> Share

  32. JANSON C
    Does ICS treatment increase the risk of pneumonia in asthma?
    Thorax. 2024 Feb 22:thorax-2023-221360. doi: 10.1136/thorax-2023-221360.
    >> Share

  33. GAY ACA, Banchero M, Carpaij O, Kole TM, et al
    Airway epithelial cell response to RSV is mostly impaired in goblet and multiciliated cells in asthma.
    Thorax. 2024 Feb 19:thorax-2023-220230. doi: 10.1136/thorax-2023-220230.
    >> Share

  34. PATEL K, Pye A, Edgar RG, Beadle H, et al
    Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD).
    Thorax. 2024;79:209-218.
    >> Share

  35. WHITTAKER H, Rothnie KJ, Quint JK
    Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
    Thorax. 2024;79:202-208.
    >> Share

  36. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Ten Hacken NHT, et al
    Airway smooth muscle and long-term clinical efficacy following bronchial thermoplasty in severe asthma.
    Thorax. 2024 Feb 12:thorax-2023-220967. doi: 10.1136/thorax-2023-220967.
    >> Share

  37. NG KL, Park J, Belcher E, Moore AJ, et al
    Not all wheeze is asthma.
    Thorax. 2024 Feb 7:thorax-2023-220953. doi: 10.1136/thorax-2023-220953.
    >> Share

    January 2024
  38. BERTELS X, Lahousse L
    Understanding the aetiology of lung function impairment: the crucial role of age of onset.
    Thorax. 2024;79:106-107.
    >> Share

  39. HALL I
    Tobacco use: a smoking gun for IPF?
    Thorax. 2024;79:104-105.
    >> Share

  40. CARSIN AE, Garcia-Aymerich J, Accordini S, Dharmage S, et al
    Spirometric patterns in young and middle-aged adults: a 20-year European study.
    Thorax. 2024;79:153-162.
    >> Share

  41. SIELINOU KAMGANG KH, Rhedin SA, Almqvist C, Wintzell V, et al
    Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study.
    Thorax. 2024 Jan 6:thorax-2023-220742. doi: 10.1136/thorax-2023-220742.
    >> Share

    December 2023
  42. HOOF I, Bonnelykke K, Stranzl T, Brand S, et al
    Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma.
    Thorax. 2023 Dec 30:thorax-2023-220707. doi: 10.1136/thorax-2023-220707.
    >> Share

  43. LOEWENTHAL L, Busby J, McDowell R, Brown T, et al
    Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.
    Thorax. 2023 Dec 16:thorax-2023-220512. doi: 10.1136/thorax-2023-220512.
    >> Share

  44. XING Z, Yang T, Shi S, Meng X, et al
    Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old.
    Thorax. 2023;79:35-42.
    >> Share

  45. TRIFIRO G, Crisafulli S
    Is antidepressant use a concern for patients with COPD?
    Thorax. 2023;79:3-4.
    >> Share

  46. MIKI K, Tsujino K, Fukui M, Miki M, et al
    Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial.
    Thorax. 2023;79:23-34.
    >> Share

  47. HURT W, Youngs J, Ball J, Edgeworth J, et al
    COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
    Thorax. 2023;79:75-82.
    >> Share

  48. SIRAJ RA, Bolton CE, McKeever TM
    Association between antidepressants with pneumonia and exacerbation in patients with COPD: a self-controlled case series (SCCS).
    Thorax. 2023;79:50-57.
    >> Share

  49. BUSBY J, McDowell PJ, Pfeffer PE, Mansur AH, et al
    Ethnic variation in asthma phenotypic presentation and outcomes: a cross-sectional analysis of the UK Biobank.
    Thorax. 2023 Dec 7:thorax-2023-221101. doi: 10.1136/thorax-2023-221101.
    >> Share

  50. KHALAF Z, Bush A, Saglani S, Bloom CI, et al
    Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma.
    Thorax. 2023 Dec 7:thorax-2023-220603. doi: 10.1136/thorax-2023-220603.
    >> Share


  51. Correction: Night shift work is associated with an increased risk of asthma.
    Thorax. 2023;78:e4.
    >> Share

  52. SOUTO-MIRANDA S, Saraiva I, Spruit MA, Marques A, et al
    Core outcome set for pulmonary rehabilitation of patients with COPD: results of a modified Delphi survey.
    Thorax. 2023;78:1240-1247.
    >> Share

  53. BISGAARD H, Mikkelsen M, Rasmussen MA, Sevelsted A, et al
    Atopic and non-atopic effects of fish oil supplementation during pregnancy.
    Thorax. 2023;78:1168-1174.
    >> Share

    November 2023
  54. HAYES L, Mejia-Arangure JM, Errington A, Bramwell L, et al
    Relationship between air quality and asthma-related emergency hospital admissions in Mexico City 2017-2019.
    Thorax. 2023 Nov 8:thoraxjnl-2022-219262. doi: 10.1136/thorax-2022-219262.
    >> Share

  55. GERDAY S, Graff S, Moermans C, Guissard F, et al
    Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline.
    Thorax. 2023;78:1138-1141.
    >> Share

  56. ECHEVARRIA C, Steer J, Prasad A, Quint JK, et al
    Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD.
    Thorax. 2023;78:1090-1096.
    >> Share

    October 2023
  57. HANSEN H, Torre A, Kallemose T, Ulrik CS, et al
    Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation - a secondary responder analysis.
    Thorax. 2023;78:1039-1042.
    >> Share

  58. BUTTERY SC
    Getting the best from pulmonary rehabilitation.
    Thorax. 2023;78:951-952.
    >> Share

  59. WARD TJ, Plumptre CD, Fraser-Pye AV, Dolmage TE, et al
    Understanding the effectiveness of different exercise training programme designs on V?O(2peak) in COPD: a component network meta-analysis.
    Thorax. 2023;78:1035-1038.
    >> Share

  60. BEMAND TJ, Chatoor R, Natale P, Strippoli G, et al
    Acetazolamide for metabolic alkalosis complicating respiratory failure with chronic obstructive pulmonary disease or obesity hypoventilation syndrome: a systematic review.
    Thorax. 2023;78:1004-1010.
    >> Share

  61. ROSS BA, Doiron D, Benedetti A, Aaron SD, et al
    Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort.
    Thorax. 2023;78:974-982.
    >> Share

  62. VERSTRAETE K, Gyselinck I, Huts H, Das N, et al
    Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials.
    Thorax. 2023;78:983-989.
    >> Share

  63. MAN W, Chaplin E, Daynes E, Drummond A, et al
    British Thoracic Society Clinical Statement on pulmonary rehabilitation.
    Thorax. 2023;78.
    >> Share

  64. BOLTON CE
    Pulmonary rehabilitation marches on: refining, optimising and delivering through the clinical statement.
    Thorax. 2023;78.
    >> Share

    September 2023

  65. Correction: Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data.
    Thorax. 2023;78:e3.
    >> Share

  66. PATEL JH, Amaral AFS, Minelli C, Elfadaly FG, et al
    Chronic airflow obstruction attributable to poverty in the multinational Burden of Obstructive Lung Disease (BOLD) study.
    Thorax. 2023;78:942-945.
    >> Share

  67. KENDZERSKA T, Povitz M, Gershon AS, Ryan CM, et al
    Association of clinically significant obstructive sleep apnoea with risks of contracting COVID-19 and serious COVID-19 complications: a retrospective population-based study of health administrative data.
    Thorax. 2023;78:933-941.
    >> Share

  68. FINNEGAN SL, Browning M, Duff E, Harmer CJ, et al
    Brain activity measured by functional brain imaging predicts breathlessness improvement during pulmonary rehabilitation.
    Thorax. 2023;78:852-859.
    >> Share

  69. LENOIR A, Whittaker H, Gayle A, Jarvis D, et al
    Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data.
    Thorax. 2023;78:904-911.
    >> Share

    August 2023
  70. JACOB J
    Reimagining emphysema for a computational age.
    Thorax. 2023 Aug 17:thorax-2023-220458. doi: 10.1136/thorax-2023-220458.
    >> Share

  71. WHITTAKER H, Nordon C, Rubino A, Morris T, et al
    Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study.
    Thorax. 2023;78:760-766.
    >> Share

    July 2023
  72. KALLIS C, Maslova E, Morgan AD, Sinha I, et al
    Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study.
    Thorax. 2023 Jul 31:thorax-2022-219757. doi: 10.1136/thorax-2022-219757.
    >> Share

  73. PEEL A, Wang R, Ahmed W, White I, et al
    Changes in exhaled volatile organic compounds following indirect bronchial challenge in suspected asthma.
    Thorax. 2023 Jul 26:thorax-2022-219708. doi: 10.1136/thorax-2022-219708.
    >> Share

  74. LEE SH, Kim J, Kim NH, Kim OH, et al
    Gut microbiota composition and metabolite profiling in smokers: a comparative study between emphysema and asymptomatic individuals with therapeutic implications.
    Thorax. 2023 Jul 26:thoraxjnl-2021-217923. doi: 10.1136/thorax-2021-217923.
    >> Share

  75. GIE A, Davies C, Vaida F, Morrison J, et al
    Lung function tracking in children with perinatally acquired HIV following early antiretroviral therapy initiation.
    Thorax. 2023 Jul 21:thorax-2023-220197. doi: 10.1136/thorax-2023-220197.
    >> Share

  76. KENYON S, Careless D, Navaratnam V, Reddy T, et al
    Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis.
    Thorax. 2023 Jul 20:thorax-2022-219859. doi: 10.1136/thorax-2022-219859.
    >> Share

  77. HO T, Shahzad A, Jones A, Raghavan N, et al
    Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.
    Thorax. 2023 Jul 9:thorax-2022-219957. doi: 10.1136/thorax-2022-219957.
    >> Share

  78. DE MATTEIS S
    Respiratory effects of air pollution: time to stop this deadly trajectory.
    Thorax. 2023;78:635-636.
    >> Share

  79. SHAPANIS A, Jones MG, Schofield J, Skipp P, et al
    Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis.
    Thorax. 2023;78:682-689.
    >> Share

  80. WANG X, Chen L, Cai M, Tian F, et al
    Air pollution associated with incidence and progression trajectory of chronic lung diseases: a population-based cohort study.
    Thorax. 2023;78:698-705.
    >> Share

  81. YOUNG RP, Ward RC, Scott RJ, Gamble GD, et al
    Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Thorax. 2023;78:690-697.
    >> Share

    June 2023
  82. PEDERSEN ES, Kuehni CE
    Heat-related hospitalisations for asthma - challenges for research.
    Thorax. 2023 Jun 28:thorax-2023-220326. doi: 10.1136/thorax-2023-220326.
    >> Share

  83. MEME H, Amukoye E, Bowyer C, Chakaya J, et al
    Asthma symptoms, spirometry and air pollution exposure in schoolchildren in an informal settlement and an affluent area of Nairobi, Kenya.
    Thorax. 2023 Jun 6:thorax-2023-220057. doi: 10.1136/thorax-2023-220057.
    >> Share

  84. ANGELINI ED, Yang J, Balte PP, Hoffman EA, et al
    Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans.
    Thorax. 2023 Jun 2:thoraxjnl-2022-219158. doi: 10.1136/thorax-2022-219158.
    >> Share

  85. HALPIN DM
    Do the 'missing millions' of COPD patients want to be found?
    Thorax. 2023;78:531-532.
    >> Share

  86. THUDIUM RF, Ronit A, Afzal S, Colak Y, et al
    Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study.
    Thorax. 2023;78:535-542.
    >> Share

  87. NJOKU CM, Hurst JR, Kinsman L, Balogun S, et al
    COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes-a systematic review and meta-analysis.
    Thorax. 2023;78:596-605.
    >> Share

    May 2023
  88. MURPHY PB, Brueggenjuergen B, Reinhold T, Gu Q, et al
    Cost-effectiveness of home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD in the UK.
    Thorax. 2023;78:523-525.
    >> Share

  89. MUISER S, Imkamp K, Seigers D, Halbersma NJ, et al
    Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.
    Thorax. 2023;78:451-458.
    >> Share

  90. GUYATT A, John C, Williams AT, Shrine N, et al
    Mendelian randomisation of eosinophils and other cell types in relation to lung function and disease.
    Thorax. 2023;78:496-503.
    >> Share

  91. SPIELMANNS M, Gloeckl R, Jarosch I, Leitl D, et al
    Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial.
    Thorax. 2023;78:442-450.
    >> Share

    April 2023
  92. KONSTANTINOUDIS G, Minelli C, Lam HCY, Fuertes E, et al
    Asthma hospitalisations and heat exposure in England: a case-crossover study during 2002-2019.
    Thorax. 2023 Apr 17:thorax-2022-219901. doi: 10.1136/thorax-2022-219901.
    >> Share

  93. FAIZ A, Pavlidis S, Kuo CH, Rowe A, et al
    Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD.
    Thorax. 2023;78:335-343.
    >> Share

  94. HIGHAM A, Singh D
    Inhaled corticosteroid responses in COPD: do mast cells hold the answer?
    Thorax. 2023;78:323-324.
    >> Share

  95. LI X, Lai Y, Lane Z, Strollo H, et al
    Cigarette smoking is a secondary cause of folliculin loss.
    Thorax. 2023;78:402-408.
    >> Share

  96. SCHNEEBERGER T, Jarosch I, Leitl D, Gloeckl R, et al
    Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial.
    Thorax. 2023;78:326-334.
    >> Share

    March 2023
  97. BRADLEY C, Boland A, Clarke L, Dallinson N, et al
    Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Thorax. 2023 Mar 27:thorax-2022-219683. doi: 10.1136/thorax-2022-219683.
    >> Share

  98. SCOTT HA, Ng SH, McLoughlin RF, Valkenborghs SR, et al
    Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis.
    Thorax. 2023 Mar 22:thoraxjnl-2022-219268. doi: 10.1136/thorax-2022-219268.
    >> Share

  99. RAMSAHAI JM, Simpson JL, Cook A, Gibson PG, et al
    Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.
    Thorax. 2023 Mar 22:thoraxjnl-2021-217865. doi: 10.1136/thorax-2021-217865.
    >> Share

  100. RUPAREL M
    Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?
    Thorax. 2023 Mar 21:thorax-2022-219778. doi: 10.1136/thorax-2022-219778.
    >> Share

  101. BEASLEY R, Bruce P, Hatter L
    ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
    Thorax. 2023 Mar 2:thorax-2022-219979. doi: 10.1136/thorax-2022-219979.
    >> Share

  102. MCDONALD MN
    Inventing the wheel: understanding heterogeneity of response to skeletal muscle dysfunction interventions in women with COPD.
    Thorax. 2023;78:219.
    >> Share

  103. MOHAN D, Rossiter H, Watz H, Fogarty C, et al
    Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.
    Thorax. 2023;78:258-266.
    >> Share

  104. XING Z, Sun T, Janssens JP, Chai D, et al
    Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey.
    Thorax. 2023;78:274-280.
    >> Share

    February 2023
  105. LEWIS A, Osadnik CR
    Changing practice by changing pressures: a role for oscillating positive expiratory pressure in chronic obstructive pulmonary disease.
    Thorax. 2023;78:113-115.
    >> Share

  106. ALGHAMDI SM, Alsulayyim AS, Alasmari AM, Philip KEJ, et al
    Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial.
    Thorax. 2023;78:136-143.
    >> Share

  107. COUSINS M, Hart K, Kotecha SJ, Henderson AJ, et al
    Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease.
    Thorax. 2023 Feb 1:thoraxjnl-2022-219301. doi: 10.1136/thorax-2022-219301.
    >> Share

    January 2023
  108. KIVISTO JE, Protudjer JLP, Karjalainen J, Bergstrom A, et al
    Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020.
    Thorax. 2023 Jan 2:thorax-2022-219539. doi: 10.1136/thorax-2022-219539.
    >> Share

  109. SINGH S, Moore LSP, Mughal N, Ho M, et al
    Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease.
    Thorax. 2023;78:110-111.
    >> Share

  110. ZHANG T, Zhou R, Wang T, Xin Y, et al
    Effects of traditional mind-body movement therapy on chronic cardiopulmonary dyspnoea: a systematic review and meta-analysis.
    Thorax. 2023;78:69-75.
    >> Share

  111. ISLAM JY, Hoppin J, Mora AM, Soto-Martinez ME, et al
    Respiratory and allergic outcomes among 5-year-old children exposed to pesticides.
    Thorax. 2023;78:41-49.
    >> Share

    December 2022
  112. HEATLEY H, Tran TN, Bourdin A, Menzies-Gow A, et al
    Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma.
    Thorax. 2022 Dec 27:thorax-2022-219642. doi: 10.1136/thorax-2022-219642.
    >> Share

  113. IBRAHIM B, Achour D, Zerimech F, de Nadai P, et al
    Plasma thymic stromal lymphopoietin (TSLP) in adults with non-severe asthma: the EGEA study.
    Thorax. 2022 Dec 14:thoraxjnl-2022-219192. doi: 10.1136/thorax-2022-219192.
    >> Share

    November 2022
  114. TYDEMAN F, Pfeffer PE, Vivaldi G, Holt H, et al
    Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
    Thorax. 2022 Nov 23:thorax-2022-219591. doi: 10.1136/thorax-2022-219591.
    >> Share

  115. GAUTAM Y, Mersha TB
    Leveraging genetic ancestry to study severe asthma exacerbations in an admixed population.
    Thorax. 2022 Nov 18. pii: thorax-2022-219459. doi: 10.1136/thorax-2022-219459.
    >> Share

  116. WORGALL S
    Environmental exposures: another effect on sphingolipids in asthma?
    Thorax. 2022 Nov 11. pii: thorax-2022-219479. doi: 10.1136/thorax-2022-219479.
    >> Share

  117. ALLAM VSRR, Pavlidis S, Liu G, Kermani NZ, et al
    Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.
    Thorax. 2022 Nov 7. pii: thorax-2021-218555. doi: 10.1136/thorax-2021-218555.
    >> Share

  118. KONSTANTINOUDIS G, Minelli C, Vicedo-Cabrera AM, Ballester J, et al
    Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007-2018.
    Thorax. 2022;77:1098-1104.
    >> Share

  119. DA SILVA SENA CR, de Queiroz Andrade E, de Gouveia Belinelo P, Percival E, et al
    Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age.
    Thorax. 2022;77:1106-1112.
    >> Share

  120. MEGHJI J, Mortimer K, Mpangama S
    TB and COPD in low-income settings: a collision of old foes.
    Thorax. 2022;77:1057-1058.
    >> Share

  121. KAMENAR K, Hossen S, Gupte AN, Siddharthan T, et al
    Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies.
    Thorax. 2022;77:1088-1097.
    >> Share

  122. AHMADIAN S, Sin DD, Lynd L, Harrison M, et al
    Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.
    Thorax. 2022;77:1079-1087.
    >> Share

    September 2022
  123. HERRERA-LUIS E, Mak ACY, Perez-Garcia J, Martin-Gonzalez E, et al
    Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth.
    Thorax. 2022 Sep 30. pii: thorax-2022-218755. doi: 10.1136/thorax-2022-218755.
    >> Share

  124. HALL I, Walker S, Holgate ST
    Respiratory research in the UK: investing for the next 10 years.
    Thorax. 2022;77:851-853.
    >> Share

    August 2022
  125. CARRARO S, Ferraro VA, Zanconato S
    From bronchiolitis endotyping to asthma risk assessment.
    Thorax. 2022 Aug 19. pii: thorax-2022-219388. doi: 10.1136/thorax-2022-219388.
    >> Share

  126. SOREMEKUN S, Heaney LG, Skinner D, Bulathsinhala L, et al
    Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.
    Thorax. 2022 Aug 3. pii: thorax-2021-217032. doi: 10.1136/thorax-2021-217032.
    >> Share

  127. KUNOE A, Sevelsted A, Chawes BLK, Stokholm J, et al
    Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life.
    Thorax. 2022;77:745-751.
    >> Share

  128. BURNS KEA, Stevenson J, Laird M, Adhikari NKJ, et al
    Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.
    Thorax. 2022;77:752-761.
    >> Share

  129. KIM N, Kwak G, Rodriguez J, Livraghi-Butrico A, et al
    Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
    Thorax. 2022;77:812-820.
    >> Share

    July 2022
  130. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    >> Share

  131. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    >> Share

  132. KEARNS N, Williams M, Bruce P, Black M, et al
    Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial.
    Thorax. 2022 Jul 18. pii: thorax-2022-219052. doi: 10.1136/thorax-2022-219052.
    >> Share

  133. FARNE H, Lin L, Jackson DJ, Rattray M, et al
    In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection.
    Thorax. 2022 Jul 5. pii: thoraxjnl-2021-217389.
    >> Share

  134. D'CRUZ RF, Kaltsakas G
    Does impaired respiratory function lead to sudden cardiac death?
    Thorax. 2022;77:641-642.
    >> Share

  135. NICI L
    Improving the lives of individuals with chronic respiratory disease: the need for innovation.
    Thorax. 2022;77:636-637.
    >> Share

  136. DAYNES E, Greening N, Singh SJ
    Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD.
    Thorax. 2022;77:690-696.
    >> Share

  137. COX NS, McDonald CF, Mahal A, Alison JA, et al
    Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.
    Thorax. 2022;77:643-651.
    >> Share

  138. CHENG YJ, Chen ZG, Yao FJ, Liu LJ, et al
    Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study.
    Thorax. 2022;77:652-662.
    >> Share

    June 2022
  139. SHIMA H, Tanabe N, Oguma A, Shimizu K, et al
    Subtyping emphysematous COPD by respiratory volume change distributions on CT.
    Thorax. 2022 Jun 29. pii: thoraxjnl-2021-218288.
    >> Share

  140. NAIR AA, Rv L, Christopher DJ
    'Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema'.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2022-218908.
    >> Share

  141. WU CC, Wang CC, Chung WY, Sheu CC, et al
    Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2021-218396.
    >> Share

  142. PASCHALAKI K, Rossios C, Pericleous C, MacLeod M, et al
    Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD.
    Thorax. 2022;77:616-620.
    >> Share

  143. JANSON C
    Inhaled corticosteroids in COPD: risk and benefits.
    Thorax. 2022;77:530-531.
    >> Share

  144. EKLOF J, Ingebrigtsen TS, Sorensen R, Saeed MI, et al
    Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.
    Thorax. 2022;77:573-580.
    >> Share

    May 2022
  145. WANG AL, Lahousse L, Dahlin A, Edris A, et al
    Novel genetic variants associated with inhaled corticosteroid treatment response in older adults with asthma.
    Thorax. 2022 May 2. pii: thoraxjnl-2021-217674.
    >> Share

    April 2022
  146. MOITRA S, Carsin AE, Abramson MJ, Accordini S, et al
    Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS.
    Thorax. 2022 Apr 27. pii: thoraxjnl-2021-217867.
    >> Share

  147. ANNANGI S, Nutalapati S, Sturgill J, Flenaugh E, et al
    Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease.
    Thorax. 2022;77:351-356.
    >> Share

    March 2022
  148. DOLBY T, Nafilyan V, Morgan A, Kallis C, et al
    Relationship between asthma and severe COVID-19: a national cohort study.
    Thorax. 2022 Mar 30. pii: thoraxjnl-2021-218629.
    >> Share

  149. BARBER CM, Cullinan P, Feary J, Fishwick D, et al
    British Thoracic Society Clinical Statement on occupational asthma.
    Thorax. 2022 Mar 21. pii: thoraxjnl-2021-218597.
    >> Share

  150. GYSENS F, Mestdagh P, de Bony de Lavergne E, Maes T, et al
    Unlocking the secrets of long non-coding RNAs in asthma.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218359.
    >> Share

  151. STANDL M
    Limited side effects of asthma treatment on growth and bone health in children.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218531.
    >> Share

  152. KEIRSBULCK M, Savoure M, Lequy E, Chen J, et al
    Long-term exposure to ambient air pollution and asthma symptom score in the CONSTANCES cohort.
    Thorax. 2022 Mar 2. pii: thoraxjnl-2021-218344.
    >> Share


  153. Correction: Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.
    Thorax. 2022;77:e2.
    >> Share

  154. STONE PW, Adamson A, Hurst JR, Roberts CM, et al
    Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
    Thorax. 2022;77:239-246.
    >> Share

  155. CHENG SWM, Alison J, Stamatakis E, Dennis S, et al
    Six-week behaviour change intervention to reduce sedentary behaviour in people with chronic obstructive pulmonary disease: a randomised controlled trial.
    Thorax. 2022;77:231-238.
    >> Share

    February 2022
  156. WOODCOCK A, Janson C, Rees J, Frith L, et al
    Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.
    Thorax. 2022 Feb 7. pii: thoraxjnl-2021-218088.
    >> Share

  157. GHOSH AJ, Saferali A, Lee S, Chase R, et al
    Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains.
    Thorax. 2022;77:115-122.
    >> Share

  158. EKSTROM M, Johannessen A, Abramson MJ, Benediktsdottir B, et al
    Breathlessness across generations: results from the RHINESSA generation study.
    Thorax. 2022;77:172-177.
    >> Share

    January 2022
  159. HOPKINSON NS, Lenney W, Langton-Hewer S, Bennett J, et al
    Children's charter for lung health.
    Thorax. 2022;77:11-12.
    >> Share

  160. BECKER EJ, Faiz A, van den Berge M, Timens W, et al
    Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD.
    Thorax. 2022;77:31-39.
    >> Share

    December 2021
  161. NIELSEN MB, Nordestgaard BG, Benn M, Colak Y, et al
    Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis.
    Thorax. 2021 Dec 23. pii: thoraxjnl-2021-217675.
    >> Share

  162. FOO CT, Karia S, Herre J
    Reversible bronchiectasis.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217548.
    >> Share

  163. O'BRIEN ME, Zou RH, Hyre N, Leader JK, et al
    CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217710.
    >> Share

  164. AMARAL AFS, Burney PGJ, Patel J, Minelli C, et al
    Chronic airflow obstruction and ambient particulate air pollution.
    Thorax. 2021;76:1236-1241.
    >> Share

    November 2021
  165. LEE JH, Kim TB
    Eosinophil granule proteins: what they can tell us about asthma.
    Thorax. 2021 Nov 26. pii: thoraxjnl-2021-218268.
    >> Share

  166. BEDI P, Ziegler K, Whitfield PD, Davidson D, et al
    Dysregulation of prostaglandins, leukotrienes and lipoxin A4 in bronchiectasis.
    Thorax. 2021 Nov 17. pii: thoraxjnl-2020-216475.
    >> Share

  167. STEWART I, Bloom CI
    Considerations for conducting and interpreting long-term follow-up of intervention studies: avoiding spoiled milk.
    Thorax. 2021;76:1067-1068.
    >> Share

  168. POLOSUKHIN VV, Gutor SS, Du RH, Richmond BW, et al
    Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.
    Thorax. 2021;76:1079-1088.
    >> Share

    October 2021
  169. FARNE H, Glanville N, Johnson N, Kebadze T, et al
    Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.
    Thorax. 2021 Oct 29. pii: thoraxjnl-2021-217429.
    >> Share

  170. CREESE H, Lai E, Mason K, Schluter DK, et al
    Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study.
    Thorax. 2021 Oct 14. pii: thoraxjnl-2021-217312.
    >> Share

  171. GRANGER V, Zerimech F, Arab J, Siroux V, et al
    Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
    Thorax. 2021 Oct 6. pii: thoraxjnl-2021-217343.
    >> Share

    September 2021
  172. BAGGOTT C, Hardy JK, Sparks J, Sabbagh D, et al
    Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis.
    Thorax. 2021 Sep 30. pii: thoraxjnl-2021-217124.
    >> Share

  173. KHO AT, McGeachie MJ, Li J, Chase RP, et al
    Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.
    Thorax. 2021 Sep 27. pii: thoraxjnl-2020-215523.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016